OS Therapies’ amended and restated 2023 Incentive Compensation Plan was approved with 4,515,930 votes for, 885,667 against and 2,002,913 abstentions, becoming effective September 9, 2026. The plan covers executives, employees, directors, officers, consultants and other service providers, supporting the company’s stated aim of attracting, retaining and rewarding talent.

Key Highlights

  • The plan vote included 885,667 opposing ballots and 2,002,913 abstentions.
  • Broker non-votes totaled 18,655,392 in the plan approval.
  • Holders of 26,059,902 shares participated in person or by proxy out of 46,205,601 entitled to vote.

OS Therapies Inc (AMEX: OSTX) secured approval for its amended and restated 2023 Incentive Compensation Plan with 4,515,930 votes in favor on September 9, 2026. Its stated purpose is to attract, motivate, retain and reward high-quality personnel while creating performance incentives tied to Shareholder value.

Plan Approval Takes Effect

Under the plan, its effective date is the shareholder approval date, September 9, 2026. The vote was held during the company’s 2026 annual meeting, where holders of 26,059,902 shares were present in person or represented by proxy from a total of 46,205,601 shares entitled to vote. The plan received 885,667 votes against and 2,002,913 abstentions. Broker non-votes accounted for 18,655,392 votes.

Eligible Participants Across Roles

Eligible participants include company officers, directors, employees, consultants and other service providers of OS Therapies or its related entities. Employees of the company, or of a parent or Subsidiary corporation, are eligible for incentive stock Options under the plan. The plan defines awards to include options, stock appreciation rights, restricted stock, deferred stock, Dividend equivalents, other stock-based awards and performance awards. Award agreements may document the rights granted to participants. Its stated objective is to strengthen the shared interests of participants and shareholders while encouraging maximum effort in creating shareholder value.

Compensation Plan Sets Retention Objective

The plan provides for performance incentives and awards connected to company shares. Those provisions apply to eligible people serving OS Therapies or its related entities in the capacities covered by the plan.